HBW
NMRD

Hazlett, Burt & Watson’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Hazlett, Burt & Watson’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed – – 741
2023
Q4 		$0 Hold
30
– – ﹤0.01% 739
2023
Q3 		$0 Hold
30
– – ﹤0.01% 768
2023
Q2 		$0 Hold
30
– – ﹤0.01% 727
2023
Q1 		$0 Hold
30
– – ﹤0.01% 705
2022
Q4 		$0 Hold
30
– – ﹤0.01% 651
2022
Q3 		$0 Hold
30
– – ﹤0.01% 660
2022
Q2 		$0 Hold
30
– – ﹤0.01% 617
2022
Q1 		$0 Buy
+30
New +$125 ﹤0.01% 588

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Hazlett, Burt & Watson's NMRD Position: Q1 2024 in Review

Hazlett, Burt & Watson sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 30 shares.

Hazlett, Burt & Watson first reported a position in NMRD in Q1 2022 and held it in 8 quarters. The position peaked at $0 in Q4 2023. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Hazlett, Burt & Watson reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 30 Nemaura Medical, Inc. Common Stock shares in Q1 2024.
  • Hazlett, Burt & Watson first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Hazlett, Burt & Watson's Nemaura Medical, Inc. Common Stock position peaked at $0 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2024, filed 29 Apr 2024.